questionsmedicales.fr
Thérapeutique
Hyperthermie provoquée
Hyperthermie provoquée : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hyperthermie provoquée : Questions médicales les plus fréquentes",
"headline": "Hyperthermie provoquée : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hyperthermie provoquée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-20",
"dateModified": "2025-03-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hyperthermie provoquée"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thérapeutique",
"url": "https://questionsmedicales.fr/mesh/D013812",
"about": {
"@type": "MedicalCondition",
"name": "Thérapeutique",
"code": {
"@type": "MedicalCode",
"code": "D013812",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Psammothérapie",
"alternateName": "Ammotherapy",
"url": "https://questionsmedicales.fr/mesh/D000646",
"about": {
"@type": "MedicalCondition",
"name": "Psammothérapie",
"code": {
"@type": "MedicalCode",
"code": "D000646",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.020"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diathermie",
"alternateName": "Diathermy",
"url": "https://questionsmedicales.fr/mesh/D003972",
"about": {
"@type": "MedicalCondition",
"name": "Diathermie",
"code": {
"@type": "MedicalCode",
"code": "D003972",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.280"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ultrasonothérapie",
"alternateName": "Ultrasonic Therapy",
"url": "https://questionsmedicales.fr/mesh/D014464",
"about": {
"@type": "MedicalCondition",
"name": "Ultrasonothérapie",
"code": {
"@type": "MedicalCode",
"code": "D014464",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.280.945"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chimiothérapie hyperthermique intrapéritonéale",
"alternateName": "Hyperthermic Intraperitoneal Chemotherapy",
"url": "https://questionsmedicales.fr/mesh/D000084262",
"about": {
"@type": "MedicalCondition",
"name": "Chimiothérapie hyperthermique intrapéritonéale",
"code": {
"@type": "MedicalCode",
"code": "D000084262",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.370"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Bain de vapeur",
"alternateName": "Steam Bath",
"url": "https://questionsmedicales.fr/mesh/D029002",
"about": {
"@type": "MedicalCondition",
"name": "Bain de vapeur",
"code": {
"@type": "MedicalCode",
"code": "D029002",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.640"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hyperthermie provoquée",
"alternateName": "Hyperthermia, Induced",
"code": {
"@type": "MedicalCode",
"code": "D006979",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mohammad-Amin Abdollahifar",
"url": "https://questionsmedicales.fr/author/Mohammad-Amin%20Abdollahifar",
"affiliation": {
"@type": "Organization",
"name": "Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: abdollahima@sbmu.ac.ir."
}
},
{
"@type": "Person",
"name": "Abbas Aliaghaei",
"url": "https://questionsmedicales.fr/author/Abbas%20Aliaghaei",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Jon E Sprague",
"url": "https://questionsmedicales.fr/author/Jon%20E%20Sprague",
"affiliation": {
"@type": "Organization",
"name": "The Ohio Attorney General's Center for the Future of Forensic Science, USA. Electronic address: jesprag@bgsu.edu."
}
},
{
"@type": "Person",
"name": "Amir Raoofi",
"url": "https://questionsmedicales.fr/author/Amir%20Raoofi",
"affiliation": {
"@type": "Organization",
"name": "Leishmaniasis Research Center, Department of Anatomy, Sabzevar University of Medical Sciences, Sabzevar, Iran."
}
},
{
"@type": "Person",
"name": "Shabnam Abdi",
"url": "https://questionsmedicales.fr/author/Shabnam%20Abdi",
"affiliation": {
"@type": "Organization",
"name": "Department of Anatomical Sciences & Cognitive Neuroscience, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A 6-Month clinical practice pilot study of sucroferric oxyhydroxide on nutritional status in patients on peritoneal dialysis.",
"datePublished": "2022-07-09",
"url": "https://questionsmedicales.fr/article/35810296",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12882-022-02878-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "",
"datePublished": "2022-06-07",
"url": "https://questionsmedicales.fr/article/35670083",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/01480545.2022.2083150"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tenapanor in Chinese ESRD patients with hyperphosphatemia on haemodialysis: a randomised, phase 3 trial.",
"datePublished": "2023-10-11",
"url": "https://questionsmedicales.fr/article/38186905",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/ckj/sfad216"
}
},
{
"@type": "ScholarlyArticle",
"name": "Correction of Vascular Calcification and Hyperphosphatemia in CKD Rats Treated with ASARM Peptide.",
"datePublished": "2022-08-30",
"url": "https://questionsmedicales.fr/article/36514737",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.34067/KID.0002782022"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of Serum Phosphorus on Hemoglobin: A Literature Review.",
"datePublished": "2024-08-26",
"url": "https://questionsmedicales.fr/article/39243408",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.69097/41-04-2024-03"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hyperthermie provoquée",
"item": "https://questionsmedicales.fr/mesh/D006979"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hyperthermie provoquée - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hyperthermie provoquée",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hyperthermie provoquée",
"description": "Comment diagnostiquer l'hyperthermie provoquée ?\nQuels tests sont utilisés pour confirmer l'hyperthermie ?\nQuels signes cliniques indiquent une hyperthermie ?\nL'hyperthermie est-elle toujours dangereuse ?\nComment différencier l'hyperthermie de la fièvre ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Hyperphosphatemia&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hyperthermie provoquée",
"description": "Quels sont les symptômes de l'hyperthermie provoquée ?\nL'hyperthermie provoquée cause-t-elle des douleurs ?\nPeut-on avoir des troubles de la conscience ?\nY a-t-il des signes cutanés associés ?\nL'hyperthermie provoquée affecte-t-elle la respiration ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Hyperphosphatemia&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hyperthermie provoquée",
"description": "Comment prévenir l'hyperthermie provoquée ?\nLes vêtements influencent-ils l'hyperthermie ?\nFaut-il surveiller la température corporelle ?\nLes pauses sont-elles importantes ?\nL'alimentation joue-t-elle un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Hyperphosphatemia&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hyperthermie provoquée",
"description": "Comment traiter l'hyperthermie provoquée ?\nDes médicaments sont-ils nécessaires ?\nQuelle est l'importance de l'hydratation ?\nQuand faut-il consulter un médecin ?\nLe repos est-il recommandé ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Hyperphosphatemia&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hyperthermie provoquée",
"description": "Quelles complications peuvent survenir ?\nL'hyperthermie peut-elle être mortelle ?\nQuels organes sont les plus affectés ?\nDes séquelles peuvent-elles persister ?\nComment éviter les complications graves ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Hyperphosphatemia&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hyperthermie provoquée",
"description": "Qui est le plus à risque d'hyperthermie ?\nL'exercice augmente-t-il le risque ?\nLes médicaments influencent-ils le risque ?\nL'humidité joue-t-elle un rôle ?\nLe surpoids est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Hyperphosphatemia&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hyperthermie provoquée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation clinique et la mesure de la température corporelle."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer l'hyperthermie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des évaluations physiologiques peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une hyperthermie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une température élevée, des frissons et une confusion mentale."
}
},
{
"@type": "Question",
"name": "L'hyperthermie est-elle toujours dangereuse ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, elle peut être contrôlée, mais nécessite une surveillance."
}
},
{
"@type": "Question",
"name": "Comment différencier l'hyperthermie de la fièvre ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hyperthermie est causée par des facteurs externes, alors que la fièvre est une réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'hyperthermie provoquée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vertiges, des maux de tête et une confusion."
}
},
{
"@type": "Question",
"name": "L'hyperthermie provoquée cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des douleurs musculaires et des crampes."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des troubles de la conscience ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la conscience peuvent survenir en cas d'hyperthermie sévère."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cutanés associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des rougeurs ou des éruptions cutanées peuvent apparaître en cas d'hyperthermie."
}
},
{
"@type": "Question",
"name": "L'hyperthermie provoquée affecte-t-elle la respiration ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner une respiration rapide et superficielle."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hyperthermie provoquée ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les environnements chauds et hydratez-vous régulièrement lors d'activités physiques."
}
},
{
"@type": "Question",
"name": "Les vêtements influencent-ils l'hyperthermie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, porter des vêtements légers et respirants aide à prévenir l'hyperthermie."
}
},
{
"@type": "Question",
"name": "Faut-il surveiller la température corporelle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, surveiller la température est essentiel lors d'activités à risque."
}
},
{
"@type": "Question",
"name": "Les pauses sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, prendre des pauses régulières lors d'activités physiques intenses est crucial."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée aide à maintenir une bonne régulation thermique."
}
},
{
"@type": "Question",
"name": "Comment traiter l'hyperthermie provoquée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut le refroidissement du corps et l'hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être administrés pour soulager les symptômes associés."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'hydratation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation est cruciale pour prévenir des complications graves liées à l'hyperthermie."
}
},
{
"@type": "Question",
"name": "Quand faut-il consulter un médecin ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si les symptômes persistent ou s'aggravent malgré le traitement."
}
},
{
"@type": "Question",
"name": "Le repos est-il recommandé ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le repos est essentiel pour permettre au corps de récupérer."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des coups de chaleur, des défaillances organiques et des convulsions."
}
},
{
"@type": "Question",
"name": "L'hyperthermie peut-elle être mortelle ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hyperthermie sévère non traitée peut entraîner la mort."
}
},
{
"@type": "Question",
"name": "Quels organes sont les plus affectés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le cerveau, le cœur et les reins sont particulièrement vulnérables à l'hyperthermie."
}
},
{
"@type": "Question",
"name": "Des séquelles peuvent-elles persister ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des séquelles neurologiques peuvent persister après une hyperthermie sévère."
}
},
{
"@type": "Question",
"name": "Comment éviter les complications graves ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement rapide et approprié est essentiel pour éviter les complications graves."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'hyperthermie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées, les enfants et celles avec des maladies chroniques sont plus à risque."
}
},
{
"@type": "Question",
"name": "L'exercice augmente-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice intense dans des environnements chauds augmente le risque d'hyperthermie."
}
},
{
"@type": "Question",
"name": "Les médicaments influencent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent altérer la régulation thermique et augmenter le risque."
}
},
{
"@type": "Question",
"name": "L'humidité joue-t-elle un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une humidité élevée augmente le risque d'hyperthermie en réduisant l'évaporation de la sueur."
}
},
{
"@type": "Question",
"name": "Le surpoids est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le surpoids peut augmenter le risque d'hyperthermie en réduisant l'efficacité de la thermorégulation."
}
}
]
}
]
}
Hyperphosphatemia is common in patients on peritoneal dialysis (PD). Restricting dietary phosphorus often leads to a decrease in protein intake, which may result in hypoalbuminemia. The high pill burd...
We performed a prospective, open-label, 6-month, pilot study of 17 adult PD patients from the Denver Metro Area. Patients had to use automated peritoneal dialysis for ≥ 3 months, have a serum albumin ...
The mean (SD) age and dialysis vintage was 55 ± 13 years and 3.8 ± 2.7 years, respectively. Participants' serum phosphate significantly decreased with fewer phosphate binder pills/day after switching ...
The transition to SO improved phosphorus control, phosphorus-attuned albumin, and pill burden. There were no significant changes in self-reported appetite or dietary intake during the study. These fin...
First registered at ClinicalTrials.gov ( NCT04046263 ) on 06/08/2019....
Sevelamer hydrochloride (SH) and calcium carbonate (CaCO...
The efficacy and safety of tenapanor has not been confirmed in Chinese end-stage renal disease (ESRD) patients with hyperphosphatemia on haemodialysis (HD)....
This was a randomised, double blind, phase 3 trial conducted at 26 dialysis facilities in China (https://www.chictr.org.cn/index.aspx; CTR20202588). After a 3-week washout, adults with ESRD on HD with...
Between 5 March 2021 and 8 June 2022, 77 patients received tenapanor and 73 received placebo. Tenapanor treatment (...
Tenapanor significantly reduced the serum phosphorous level versus placebo in Chinese ESRD patients on HD and was generally well tolerated....
Abnormalities in calcium, phosphorus, PTH, vitamin D metabolism, bone, and vascular calcification occur in chronic kidney disease mineral bone disorder (CKD-MBD). Calciphylaxis, involving painful, ulc...
To test our hypothesis, we assessed the effects of synthetic ASARM peptide in rats that had undergone a subtotal 5/6th nephrectomy (56NEPHREX), a rodent model of CKD-MBD. All rats were fed a high phos...
Rats that had undergone 56NEPHREX treated with ASARM peptide showed major improvements in hyperphosphatemia, blood urea nitrogen (BUN), and bone quality compared with vehicle controls. Also, ASARM-inf...
ASARM peptide infusion corrects hyperphosphatemia and improves vascular calcification, renal calcification, brain calcification, bone quality, renal function, and skin mineralization abnormalities in ...
Phosphorus is a macroelement found in the body, mostly in the bones as crystals of hydroxyapatite. Higher levels are found in patients affected by chronic kidney disease (CKD). Since the early stage o...
COPD patients frequently have abnormal serum phosphorus levels. The objective of this study was to examine the correlation between serum phosphorus levels with hospital and 90-day mortality in critica...
The MIMIC IV database was used for this retrospective cohort analysis. We extracted demographics, vital signs, laboratory tests, comorbidity, antibiotic usage, ventilation and scoring systems within t...
We included a total of 3611 patients with COPD, with a median age of 70.7 years. After adjusting for all other factors, we observed a significant positive association between serum phosphate levels wi...
In critical ill COPD patients, this study demonstrated a non-linear association between serum phosphate levels and both hospital and 90-day mortality. Notably, there was an inflection point at 3.8 mg/...
Hyperphosphatemia is associated with increased morbidity and mortality in patients with end-stage kidney disease (ESKD). Whereas clinical and observational studies have demonstrated the effectiveness ...
We analyzed de-identified data from adults on PD in Fresenius Kidney Care clinics who were prescribed SO monotherapy between May 2018 and December 2019 as part of routine clinical management. Changes ...
The mean age of the 402 patients who completed 1 year of SO was 55.2 years at baseline, and they had been on PD for an average of 19.9 months. SO was initiated with no baseline PB recorded in 36.1% of...
Patients on PD who were prescribed SO as part of routine care for phosphorus management experienced significant reductions in SP and PB pills per day and improvements in sP target achievement, suggest...
This study aimed to investigate the effect of a family-centered empowerment program on hyperphosphatemia management....
This experimental study was performed on 80 randomly selected eligible patients with hyperphosphatemia undergoing hemodialysis. Patients were assigned randomly to two groups of family-centered empower...
Inter-group comparisons showed no significant difference between FCEPG and CG in terms of the mean score of knowledge of phosphate control, adherence to dietary restriction of phosphorus intake, adher...
The findings of this study can be used in various fields of healthcare in the hospital and community....
Hyperphosphatemia is a common complication in advanced chronic kidney disease and contributes to cardiovascular morbidity and mortality. The present narrative review focuses on the management of phosp...
Objective: The aim of the study is to explore the impact of early serum phosphate levels on the prognosis of critically ill patients with sepsis. Methods: In this retrospective large cohort study, dat...